Evidence map›Paper›PMID 40400623›Full record

ArticleFrontiers in medicine2025

Phenotyping sarcoidosis: a single institution retrospective analysis.

Francesco Rocco Bertuccio, Davide Piloni, Marianna Russo, Fady Tousa, Mariachiara Crescenzi, Paola Putignano, Nicola Baio, Ida Maragò, Angelo Guido Corsico, Giulia Maria Stella

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francesco Rocco BertuccioCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Davide PiloniCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Marianna RussoCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Fady TousaCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Mariachiara CrescenziCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Paola PutignanoCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Nicola BaioCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Ida MaragòDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Angelo Guido CorsicoCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.
Giulia Maria StellaCardiothoracic and Vascular Department, Unit of Respiratory Disease, IRCCS Policlinico San Matteo, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sarcoidosis is a systemic disorder marked by the presence of non-caseating epithelioid cell granulomas. The diagnosis relies on a consistent clinical presentation, histological evidence of non-necrotizing granulomatous inflammation in one or more tissue specimens, and the exclusion of other potential etiologies of granulomatous disease. It is a heterogeneous disease with many focal points to be clarified. For instance, finding a relationship between symptom burden, race, gender, HRQoL, and pulmonary function could have therapeutic ramifications, influence clinical practice, and aid in selecting patients for specific clinical studies. Methods: A comprehensive statistical evaluation was conducted using the JMP partitioning algorithm which explores all potential divisions to identify the most predictive variables. Results: With our analysis, we tried to categorize patients from a single Institution respiratory unit to delineate clinical phenotypes in sarcoidosis. Conclusions: Larger studies using appropriate methodology should surely be carried out to address this issue and help clarify the varying contributions of genetics, socioeconomic status, environmental exposures, and other sociodemographic factors to illness severity and phenotypic presentation. Additionally, the application of transcriptomics, interdisciplinary methods, patients' disease perspectives, and the publishing of novel discoveries may contribute to enhanced clinical support and a deeper comprehension of the etiology of illness.

Indexed as

granulomatous diseasesinflammatory granulomatous diseasesinterstitial lung diseasephenotypingsarcoidosis

Identifiers

PMID40400623
PMCPMC12092213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.